Blog
RSS FeedPosted by Michael Wonder on 10 Feb 2022
Patent box legislation to promote Australian innovation
11 February 2022 - Medicines Australia notes the introduction of patent box legislation, Treasury Laws Amendment (Tax Concession for Australian ...
Posted by Michael Wonder on 04 Feb 2021
Repurposing of prescription medicines
4 February 2021 - The Therapeutic Goods Administration is conducting a public consultation that seeks to understand potential obstacles and ...
Posted by Michael Wonder on 10 Aug 2020
Australian start-ups push for bigger role in vaccine making
9 August 2020 - An Australian startup racing to develop a successful coronavirus vaccine has urged the federal government to ...
Posted by Michael Wonder on 12 Feb 2020
Australia's biotech innovations heading offshore, prompting calls for greater funding to bring them to market
11 February 2020 - The demand on the health sector has never been more evident, as the world scrambles to ...
Posted by Michael Wonder on 06 Dec 2019
Proposed changes to research and development tax incentive will discourage investment and undermine innovation
6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...
Posted by Michael Wonder on 26 Jul 2019
Intellectual property law amends will add to business uncertainty
26 July 2019 - Medicines Australia supports efforts to strengthen Australia’s Intellectual Property arrangements to be consistent with international best ...
Posted by Michael Wonder on 26 Sep 2018
The health industry as an economic priority for Victoria, joint statement
26 September 2018 - Victoria has world-leading competitive advantages in the health industry, which encompasses health and medical research, biotechnology, ...
Posted by Michael Wonder on 06 Jun 2018
Big pharma wants to invest more in Australian biotech says Greg Hunt
6 June 2018 - Big pharma is "looking at Australia as the next destination in the developed world, the emerging first-world ...
Posted by Michael Wonder on 06 Feb 2018
AusBiotech says plan to disadvantage life sciences innovation
6 February 2018 - Response to Innovation and Science Australia 2030 plan. ...
Posted by Michael Wonder on 31 Jan 2018
Industry needs clarity to invest in Australia
31 January 2018 - Medicines Australia welcomes the release of the 2030 plan by Innovation and Science Australia but seeks ...
Posted by Michael Wonder on 22 Jun 2017
Clinical trials provide $1.1b to Australian economy: MTPConnect releases report on clinical trials ecosystem in Australia
21 June 2017 - MTPConnect today released a new report ‘Clinical Trials in Australia: the economic profile and competitive position ...
Posted by Michael Wonder on 10 May 2017
MTPConnect welcomes 2017 Budget: investment in MTP research translation and commercialisation
10 May 2017 - MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has ...
Posted by Michael Wonder on 18 Apr 2017
Peak bodies unite against threat to commercialisation of Australian medical research
18 April 2017 - AusBiotech has joined fellow organisations - Research Australia, Medicines Australia, Medical Technologies Association of Australia and ...
Posted by Michael Wonder on 10 Apr 2017
QUT, MTPConnect and industry partnership will help to ensure Australia stays globally competitive
10 April 2017 - Medicines Australia warmly welcomes the commencement of The Bridge Program – an initiative of a consortium ...
Posted by Michael Wonder on 06 Apr 2017
AusBiotech says R&D Tax Incentive critical to 2030 Innovation Strategy
6 April 2017 - Preserving the R&D Tax Incentive will be top priority as AusBiotech coordinates comment for Innovation and ...